Close

UTHR Financial Facts

(Loss) income from discontinued operations, net of tax: 0
Discontinued operations (in dollars per share): 0.07
See Full Income Statement

Deferred tax assets: 191M
Other current assets: 6.28M
See Full Balance Sheet

United Therapeutics Corp. (UTHR) Earnings

  |   Expand Research on UTHR
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +24.1% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +2.1% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/3/22 Q222 N/A$4.42 N/A N/A$458.97M N/A N/A N/A
5/4/22 Q122 $5.03$3.34 +$1.69$461.9M$420.02M N/A Details
2/24/22 Q421 $3.51$3.72 -$0.21$415.2M$427.62M N/A Details
11/3/21 Q321 $4.16$3.59 +$0.57$444.7M$421.45M N/A Details
8/4/21 Q221 $4.09$3.02 +$1.07$446.5M$378.75M N/A Details
5/5/21 Q121 $3.49$2.94 +$0.55$379.1M$368.95M N/A Details
2/24/21 Q420 $3.31$3.14 +$0.17$384.9M$362.04M N/A Details
10/28/20 Q320 $3.88$2.78 +$1.10$380.1M$356.95M N/A Details